Phase 1b/2 Study of Orally Administered Pexidartinib in Combination with Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma

Mendez, J. S., Cohen, A. L., Eckenstein, M., Jensen, R. L., Burt, L. M., Salzman, K. L., Chamberlain, M., Hsu, H. H., Hutchinson, M., Iwamoto, F., Ligon, K. L., Mrugala, M. M., Pelayo, M., Plotkin, S. R., Puduvalli, V. K., Raizer, J., Reardon, D. A., Sterba, M., Walbert, T., … Colman, H. (2024). Phase 1b/2 Study of Orally Administered Pexidartinib in Combination with Radiation Therapy and Temozolomide in Patients with Newly Diagnosed Glioblastoma. Neuro-Oncology Advances. https://doi.org/10.1093/noajnl/vdae202
Authors:
Joe Mendez
Adam L. Cohen
Midori Eckenstein
Randy L. Jensen
Lindsay Burt
Karen L. Salzman
Marc C. Chamberlain
Henry H. Hsu
Marguerite Hutchinson
Fábio M. Iwamoto
Keith L. Ligon
Maciej M. Mrugała
Michael Pelayo
Scott R. Plotkin
Vinay K. Puduvalli
Jeffrey J. Raizer
David A. Reardon
Michael Sterba
Tobias Walbert
Brian L. West
Eric T. Wong
Chao Zhang
Howard Colman
Affiliated Authors:
Fábio M. Iwamoto
Subjects:
Gliomas (OpenAlex Topic)
Management of Brain Metastases in Cancer Patients (OpenAlex Topic)
Advancements in Colorectal Cancer Research (OpenAlex Topic)
Author Keywords:
csf1r
glioblastoma
kit
tumor microenvironment
pexidartinib
elink
Publication Type:
Article
Unique ID:
10.1093/noajnl/vdae202
DOI:
10.1093/noajnl/vdae202
Journal:
Neuro-Oncology Advances
Publication Date:
Data Source:
OpenAlex
Source Link:
View OpenAlex Record
View PubMed Record
View Web of Science Record

Record Created: